ログイン
言語:

WEKO3

  • トップ
  • コミュニティ
  • ランキング
AND
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "1be00882-699f-4d0a-b1db-5d0d5b7413a4"}, "_deposit": {"id": "3970", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "3970"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00003970", "sets": ["461:462"]}, "author_link": ["8319", "8320", "8321", "8322", "8323", "8324"], "control_number": "3970", "item_1628147817048": {"attribute_name": "\u51fa\u7248\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_6_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2008-04", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "4", "bibliographicPageEnd": "418", "bibliographicPageStart": "413", "bibliographicVolumeNumber": "42", "bibliographic_titles": [{"bibliographic_title": "JOURNAL OF CLINICAL GASTROENTEROLOGY"}]}]}, "item_6_description_30": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7\uff08\u30b3\u30f3\u30c6\u30f3\u30c4\u306e\u7a2e\u985e\uff09", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_31": {"attribute_name": "\u30d5\u30a9\u30fc\u30de\u30c3\u30c8\uff1amime\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"subitem_description": "application/pdf", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "\u5f15\u7528", "attribute_value_mlt": [{"subitem_description": "JOURNAL OF CLINICAL GASTROENTEROLOGY. 42(4):413-418(2008)", "subitem_description_type": "Other"}]}, "item_6_link_3": {"attribute_name": "\u4fe1\u5dde\u5927\u5b66\u7814\u7a76\u8005\u7dcf\u89a7\u3078\u306e\u30ea\u30f3\u30af", "attribute_value_mlt": [{"subitem_link_text": "Tanaka, E", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.HFDCHekh.html"}]}, "item_6_link_67": {"attribute_name": "WoS", "attribute_value_mlt": [{"subitem_link_text": "Web of Science", "subitem_link_url": "http://gateway.isiknowledge.com/gateway/Gateway.cgi?\u0026GWVersion=2\u0026SrcAuth=ShinshuUniv\u0026SrcApp=ShinshuUniv\u0026DestLinkType=FullRecord\u0026DestApp=WOS\u0026KeyUT=000254629300017"}]}, "item_6_publisher_4": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "LIPPINCOTT WILLIAMS \u0026 WILKINS"}]}, "item_6_select_64": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "author"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0192-0790", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0192-0790", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_40": {"attribute_name": "\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00257261", "subitem_source_identifier_type": "NCID"}]}, "item_6_text_69": {"attribute_name": "wosonly authkey", "attribute_value_mlt": [{"subitem_text_value": "alanine aminotransferase; free fatty acids; oxidative stress; soluble tumor necrosis factor receptors; ferritin"}]}, "item_6_text_70": {"attribute_name": "wosonly keywords", "attribute_value_mlt": [{"subitem_text_value": "FATTY LIVER-DISEASE; ACTIVATED RECEPTOR-ALPHA; HEPATIC STEATOSIS; JAPANESE PATIENTS; CONTROLLED-TRIAL; EXPRESSION; OMEGA-3-FATTY-ACIDS; PIOGLITAZONE; CIRRHOSIS; ENZYMES"}]}, "item_6_textarea_68": {"attribute_name": "wosonly abstract", "attribute_value_mlt": [{"subitem_textarea_value": "Recent studies have demonstrated that n-3 polyunsaturated fatty acids ameliorate nonalcoholic fatty liver disease. Although eicosapentaenoic acid (EPA), one of the major components of n-3 polyunsaturated fatty acids, is widely used as an antilipidemic agent, its single efficacy for nonalcoholic steatohepatitis (NASH) remains unclear. As such, we aimed to evaluate the efficacy and safety of EPA on 23 biopsy-proven NASH patients in a pilot trial. Highly purified EPA (2700 mg/d) was administered for 12 months and efficacy was assessed by biochemical parameters and liver histology. All patients completed the treatment with no adverse events, indicating acceptable tolerance to the treatment. After 12 months, serum alanine amino transferase levels were significantly improved (from 79 36 to 50 120 U/L), and serum free fatty acids, plasma soluble tumor necrosis factor receptor 1 and 2 levels, and serum ferritin and thioredoxin levels, which may reflect hepatic oxidative stress, were significantly decreased. Body weight, blood glucose, insulin, and adiponectin concentrations remained unchanged. Seven of the 23 patients consented to undergo posttreatment liver biopsy, which showed improvement of hepatic steatosis and fibrosis, hepatocyte ballooning, and lobular inflammation in 6 patients. In conclusion, EPA treatment seems to be safe and efficacious for patients with NASH, largely due to its anti-inflammatory and antioxidative properties. To confirm these results, appropriately powered, controlled trials are needed."}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Tanaka, Naoki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "8319", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sano, Kenji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "8320", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Horiuchi, Akira", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "8321", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tanaka, Eiji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "8322", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kiyosawa, Kendo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "8323", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Aoyama, Toshifumi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "8324", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2015-09-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "EPApilot_JCGR1[1].pdf", "filesize": [{"value": "79.4 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 79400.0, "url": {"label": "EPApilot_JCGR1[1].pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/3970/files/EPApilot_JCGR1[1].pdf"}, "version_id": "43c0ba83-dda1-406f-b2db-d234d92cabb2"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis", "subitem_title_language": "en"}]}, "item_type_id": "6", "owner": "1", "path": ["461/462"], "permalink_uri": "http://hdl.handle.net/10091/1160", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2008-09-18"}, "publish_date": "2008-09-18", "publish_status": "0", "recid": "3970", "relation": {}, "relation_version_is_last": true, "title": ["Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis"], "weko_shared_id": 3}
  1. 050 医学部, 大学院医学系研究科
  2. 0501 学術論文

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis

http://hdl.handle.net/10091/1160
618b8079-d8c8-41cf-b18d-600d395bcffd
名前 / ファイル ライセンス アクション
EPApilot_JCGR1[1].pdf EPApilot_JCGR1[1].pdf (79.4 kB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2008-09-18
タイトル
言語 en
タイトル Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
言語
言語 eng
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ journal article
著者 Tanaka, Naoki

× Tanaka, Naoki

WEKO 8319

en Tanaka, Naoki

Search repository
Sano, Kenji

× Sano, Kenji

WEKO 8320

en Sano, Kenji

Search repository
Horiuchi, Akira

× Horiuchi, Akira

WEKO 8321

en Horiuchi, Akira

Search repository
Tanaka, Eiji

× Tanaka, Eiji

WEKO 8322

en Tanaka, Eiji

Search repository
Kiyosawa, Kendo

× Kiyosawa, Kendo

WEKO 8323

en Kiyosawa, Kendo

Search repository
Aoyama, Toshifumi

× Aoyama, Toshifumi

WEKO 8324

en Aoyama, Toshifumi

Search repository
信州大学研究者総覧へのリンク
氏名 Tanaka, E
URL http://soar-rd.shinshu-u.ac.jp/profile/ja.HFDCHekh.html
出版者
出版者 LIPPINCOTT WILLIAMS & WILKINS
引用
内容記述タイプ Other
内容記述 JOURNAL OF CLINICAL GASTROENTEROLOGY. 42(4):413-418(2008)
書誌情報 JOURNAL OF CLINICAL GASTROENTEROLOGY

巻 42, 号 4, p. 413-418, 発行日 2008-04
資源タイプ(コンテンツの種類)
内容記述タイプ Other
内容記述 Article
ISSN
収録物識別子タイプ PISSN
収録物識別子 0192-0790
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AA00257261
出版タイプ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
WoS
表示名 Web of Science
URL http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=ShinshuUniv&SrcApp=ShinshuUniv&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000254629300017
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 07:51:28.996016
Show All versions

Share

Mendeley CiteULike Twitter Facebook Print Addthis

Cite as

Export

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by CERN Data Centre & Invenio


Powered by CERN Data Centre & Invenio